Mark Lackner, Chief Scientific Officer: Zentalis Pharmaceuticals ZNTL Sell · Filed 25/02/05

Trade details

Type: Insider sale
Amount: $24,569.28
Shares · price: 14,368 sh · $1.71 a share
Held after: 512,856 sh
Stock: Zentalis Pharmaceuticals ZNTL
Person: Mark LacknerChief Scientific Officer
Trade date: 25/02/03
Filed: 25/02/05
Days to filing: 2 days

Sold 2.7% of holdings

Share of holding sold: 2.7%

Zentalis Pharmaceuticals trades, last 26 weeks

What else happened in Zentalis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/01/04~25/03/05

Mark Lackner's recent trades

Lackner MarkChief Scientific Officer
Planned saleZentalis Pharmaceuticals
Planned sale
Zentalis Pharmaceuticals
ZNTL
$24.6K
14,368 sh
$24.6K
Filed 25/02/03
Traded 25/02/03
Mark LacknerChief Scientific Officer
SellZentalis Pharmaceuticals
Sell
Zentalis Pharmaceuticals
ZNTL
$13.8K
4,411 sh
$13.8K
Filed 25/01/03
Traded 25/01/02
Mark LacknerChief Scientific Officer
SellZentalis Pharmaceuticals
Sell
Zentalis Pharmaceuticals
ZNTL
$18.3K
1,585 sh
$18.3K
Filed 24/02/05
Traded 24/02/02